- Imdelltra plus durvalumab extends median overall survival to 21.1 months versus 12.7 months with durvalumab alone
The combination of Imdelltra and Durvalumab showed a median overall survival of 21.1 months compared to 12.7 months with Durvalumab alone.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.